STIRENA

Dual stimuli-responsive nanoparticles as novel topical drug delivery systems

Coordinatore	QUEEN MARY UNIVERSITY OF LONDON    more  Organization address address: 327 MILE END ROAD city: LONDON postcode: E1 4NS contact info Titolo: Dr. Nome: Marina Cognome: Resmini Email: send email Telefono: +44 20 7882 3268
Nazionalità Coordinatore	United Kingdom [UK]
Totale costo	221˙606 €
EC contributo	221˙606 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2012-IEF
Funding Scheme	MC-IEF
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-06-01   -   2015-05-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	QUEEN MARY UNIVERSITY OF LONDON  Organization address address: 327 MILE END ROAD city: LONDON postcode: E1 4NS contact info Titolo: Dr. Nome: Marina Cognome: Resmini Email: send email Telefono: +44 20 7882 3268	UK (LONDON)	coordinator	221˙606.40

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'This project aims to develop new stimuli-responsive nanoparticles (SRN’s) reacting to changes in temperature and pH, and to evaluate their applications for both topical and transdermal drug delivery. New multifunctional materials, thermoresponsive as well as nanogels and dual pH-Tm responsive materials, using a combination of poly(N-isopropylacrylamide), poly(2-oxazolines) and chitosan will be synthesized and characterized. The main objective of this project will be to develop stimuli responsive nanoparticles based on the new multifunctional materials and evaluate their use as drug delivery nano-systems for skin application. Different techniques such as coprecipitation, oil/water solvent evaporation and high dilution radical polymerization will be used to generate nanoparticle with different physicochemical characteristics. Their clinical potential will be evaluated using preclinical in vitro skin models. The stimuli responsive nanoparticles proposed in this project may be characterized as an innovative approach to the development of new multifunctional skin delivery systems allowing the drug to be released, only when the tissue itself give the appropriate message, in terms of temperature and/or pH response.'